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Abstract
Background: Identifying modifiable factors that increase women’s vulnerability to HIV is a critical step in developing
effective female-initiated prevention interventions. The primary objective of this study was to pool individual participant
data from prospective longitudinal studies to investigate the association between intravaginal practices and acquisition of
HIV infection among women in sub-Saharan Africa. Secondary objectives were to investigate associations between
intravaginal practices and disrupted vaginal flora; and between disrupted vaginal flora and HIV acquisition.
Methods and Findings: We conducted a meta-analysis of individual participant data from 13 prospective cohort studies
involving 14,874 women, of whom 791 acquired HIV infection during 21,218 woman years of follow-up. Data were pooled
using random-effects meta-analysis. The level of between-study heterogeneity was low in all analyses (I
2 values 0.0%–
16.1%). Intravaginal use of cloth or paper (pooled adjusted hazard ratio [aHR] 1.47, 95% confidence interval [CI] 1.18–1.83),
insertion of products to dry or tighten the vagina (aHR 1.31, 95% CI 1.00–1.71), and intravaginal cleaning with soap (aHR
1.24, 95% CI 1.01–1.53) remained associated with HIV acquisition after controlling for age, marital status, and number of sex
partners in the past 3 months. Intravaginal cleaning with soap was also associated with the development of intermediate
vaginal flora and bacterial vaginosis in women with normal vaginal flora at baseline (pooled adjusted odds ratio [OR] 1.24,
95% CI 1.04–1.47). Use of cloth or paper was not associated with the development of disrupted vaginal flora. Intermediate
vaginal flora and bacterial vaginosis were each associated with HIV acquisition in multivariable models when measured at
baseline (aHR 1.54 and 1.69, p,0.001) or at the visit before the estimated date of HIV infection (aHR 1.41 and 1.53, p,0.001),
respectively.
Conclusions: This study provides evidence to suggest that some intravaginal practices increase the risk of HIV acquisition
but a direct causal pathway linking intravaginal cleaning with soap, disruption of vaginal flora, and HIV acquisition has not
yet been demonstrated. More consistency in the definition and measurement of specific intravaginal practices is warranted
so that the effects of specific intravaginal practices and products can be further elucidated.
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HIV-infected women outnumber men in many sub-Saharan
African countries [1]. Novel female-initiated preventive methods have,
so far, proved elusive [2,3], so identifying new modifiable factors that
affect women’s vulnerability to HIV might help in the development of
newpreventive interventions [4].Women use a wide range of products,
applied in a variety of ways inside the vagina, to manage their sexual
relationships, menstruation, and to improve wellbeing [5].
It has been hypothesised that some intravaginal practices could
increase the risk of HIV infection by causing physical abrasions [4] or
by disrupting the vaginal epithelium and increasing the occurrence of
bacterial vaginosis (BV) [6–8]. An association between BV and HIV
has been shown in cross-sectional and prospective studies [9,10] and,
more recently, intermediate grades of vaginal flora have also been
associated with an increased risk of HIV acquisition [11]. However,
the evidence linking intravaginal practices, BV, and HIV infection is
currently inconclusive [8,12,13], as is evidence of associations between
these practices and BV [12].A recent systematicreview found that few
prospective studies recorded intravaginal practices consistently and
that there was substantial heterogeneity between studies reporting
associations between intravaginal practices and HIV [12]. Even large
individual studies lack statistical power to examine the effects of
specific intravaginal practices on HIV acquisition. Combining
individual participant data from different studies might overcome
some of these problems because data can be analysed consistently
across studies and statistical power and precision can be increased
[14]. Our overall aim was to determine whether specific vaginal
practices increase the risk of a woman acquiring HIV infection by
facilitating disturbances in vaginal flora or vaginal epithelial
disruption. The primary objective of this study was to pool individual
participant data from prospective longitudinal studies to investigate
the association between intravaginal practices and acquisition of HIV
i n f e c t i o na m o n gw o m e ni ns u b - S a h a r a nA f r i c a .S e c o n d a r yo b j e c t i v e s
were to investigate associations between intravaginal practices and
disrupted vaginal flora; and between disrupted vaginal flora and HIV
acquisition.
Methods
The study protocol specified hypotheses, inclusion criteria, and
methods of analysis, and is available at http://www.ispm.ch/
uploads/media/VP_IPD_protocol__final_090205_01.pdf. The
review was reported according to the guidelines of the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) group (Text S1).
Study Selection
Potentially eligible studies were cohort studies and randomised
controlled trials conducted in sub-Saharan Africa that had
collected data prospectively about both intravaginal practices
and incident HIV infection in females aged 10 y or older. We did
not consider studies examining associations between disrupted
vaginal flora and HIV unless data on intravaginal practices were
also collected. We excluded studies in which participants were
asked not to use intravaginal practices during the study or where
the primary vaginal practice was female genital cutting or genital
surgery. We also excluded studies involving vaginal microbicides
or placebo products, tampons, or other devices to deliver
medication. However, the control group in such studies was
eligible for inclusion if they did not receive these interventions.
We identified studies using the results of a systematic review of
published studies, which has been described elsewhere [12]. We
obtained published reports of all studies included in the previous
review and asked experts in the field to identify additional studies
that had collected data about both intravaginal practices and
incident HIV infections. We tried to contact the corresponding
author or principal investigator of all potentially eligible studies by e-
mail to determine whether relevant data had been collected and to
invite them to contribute to the individual participant data meta-
analysis. Weincluded eligible studies for which wehad receivedboth
asignedagreementtoparticipate andadatasetby16thMarch2009.
All included studies were approved by relevant country-specific and
institutional ethical review boards and all participants within each
study provided written informed consent for the original studies.
Data Collection
We used protocols, questionnaires, and publications from
included studies, and information from investigators to determine
whether requested variables had been collected or could be
derived. The final variable list included: HIV infection, intravag-
inal practices, vaginal flora status, herpes simplex virus infection
(HSV-2) status, age, education, religion, marital status, employ-
ment, age at first sex, numbers of sex partners, sex in exchange for
money, pregnancy and contraception, and general condom use
(consistent, inconsistent, or never). A named investigator for each
included study provided access to the dataset, answered questions
about the study procedures and coding of variables, and
contributed to interpretation of results and revising the manu-
script. For most studies we obtained raw data and recoded these in
house (MFC, KS, or SCF). For two studies, a data manager
provided a dataset, coded according to our predefined scheme.
Outcome and Exposure Measures
The primary outcome was HIV infection diagnosed within the
first 2 y, using the diagnostic criteria defined by each individual
study. We included women with a negative HIV test at the
baseline visit and at least one follow-up HIV test and estimated the
date of HIV infection as the midpoint between the last negative
and the first positive test.
Intravaginal practices were the main exposures and were based
on self-reported data collected in face-to-face interviews in all but
one study, which instead used audio computer-assisted self-
interviewing [15]. Definitions were based on a published
classification system [6]. After examining the data available in
individual studies, we defined five separate intravaginal practices
(Box 1). We used baseline data about current practices (that is,
those from the 1 to 3 mo preceding the start of the study), since
there were too few studies reporting repeated measures of these
variables to consider changes in practices over time. The reference
group was women not at increased risk of acquiring HIV infection
through intravaginal practices, and included women using no
intravaginal practice or water.
Vaginal flora status was considered as both an exposure and an
outcome, and assessed using scores from Gram-stained vaginal
smears [16,17], or Amsel clinical criteria [18]. We used the
Nugent score if results from more than one method were available
[16]. BV was defined as a Nugent score of 7–10, Ison-Hay grade
III, or the presence of three or more Amsel criteria. Intermediate
vaginal flora was defined as a Nugent score of 4–6 [11] or Ison-
Hay grade II. Two studies used Amsel criteria only and could not
be included in analyses that included intermediate vaginal flora as
an exposure or outcome [19,20].
Assessment of the Risk of Bias
We assessed the potential for bias in each cohort study, arising
from prespecified methodological domains [21]: description of
participation and evidence of bias; definitions of diagnostic
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missing data; and measurement of main confounders.
Statistical Analysis
Association between intravaginal practices and HIV
infection. For the primary objective we included all women
and used Cox proportional hazards models to examine
associations in each study between each intravaginal practice at
baseline and HIV acquisition, and expressed these as the hazard
ratio (HR) and 95% confidence intervals (CIs). Follow-up time was
measured until the first of: estimated date of HIV infection; the last
follow-up visit; the end of the study; or after 2 y of follow-up. We
pooled data if the level of between-study heterogeneity was mild or
moderate, defined as a value from the I
2 statistic below 50% [22].
We used two methods [14]: for all study objectives we used
random effects meta-analysis to combine effect estimates from
individual strata (two-stage method); for analyses with HIV
acquisition as the outcome we also used stratified, fixed effects
Cox regression, with studies as the strata (one-stage method). Both
methods gave very similar results. The proportional hazards
assumption, tested on the basis of Scho ¨nfeld residuals, was not
violated in any model. All statistical analyses were conducted using
Stata (version 10, Stata Corporation).
We looked for statistical evidence of confounding of the
association between intravaginal practices and HIV infection in
each individual study and for each intravaginal practice by
comparing the univariable HR with the HR from bivariable
models including baseline measures of each of the following
prespecified factors: marital status; numbers of sex partners;
condom use; contraception; educational level; religion; employ-
ment; age at first intercourse; having received goods or money in
exchange for sex; pregnancy; and HSV-2 status. If inclusion of the
variable resulted in the HR changing by more than 10% in one or
more individual studies we considered it for inclusion in
multivariable analyses [23]. We controlled for age in all multivar-
iablemodels.Wepresentresultsfrom models thatalsocontrolledfor
marital status and number of sex partners during the previous 3 mo
as recorded at cohort entry because these were the variables that
fulfilled our criteria most often. The results were very similar to
those from models that controlled for a larger common set of
variables, or controlled for different variables in each study.
We then examined the role of BV. We aimed to control for
time-varying confounding by BV [24], but there were too many
differences between studies in the frequency and timing of vaginal
specimen collection to use fully time-updated measures. We
therefore conducted two exploratory analyses in multivariable
models to see, qualitatively, whether there was attenuation of the
HR; using either the result of the baseline test or the last available
test for BV before the estimated date of HIV infection, or before
the date of censoring.
Associations between intravaginal practices and changes
in vaginal flora status. To examine associations between
intravaginal practices and short-term changes in vaginal flora
status we included womenwhohad normal vaginal flora at baseline,
assessed using Gram-stain criteria, and a follow-up assessment
within the first year of enrolment. We categorised vaginal flora
statusat follow-upasnormal, intermediate, orBV.We used ordered
logistic regression with a proportional odds model [25]. The
assumption of the model is that the odds ratio (OR) associated with
an intravaginal practice for the odds of intermediate vaginal flora or
BV compared with normal vaginal flora is equal to the OR for BV
compared with normal or intermediate flora. The model therefore
estimates a single OR from the data.
Association between disrupted vaginal flora and HIV
acquisition. To examine the association between disrupted
vaginal flora and HIV acquisition we included all women with
vaginal flora assessed by Gram-stain at baseline. We considered
vaginal flora status as a three-level ordered exposure and used Cox
proportional hazards regression to estimate the HR (and 95% CI)
for incident HIV infection in the first 2 y of follow-up.
Box 1. Definitions of intravaginal practices used in this study.
Intravaginal Practice Definition
Cleaning with water Cleaning inside the vagina, beyond the introitus, with water as the only product. Can be with
or without specific mention of fingers, other materials, or douching devices to introduce water
inside the vagina.
Cleaning with soap Cleaning inside the vagina, beyond the introitus, with generic ‘‘soap’’ or ‘‘household soap,’’ or
named proprietary bath soaps. Can be with or without specific mention of fingers, other
materials, or douching devices to introduce soap lather inside the vagina.
Cleaning with other
household products
Cleaning inside the vagina, beyond the introitus, with products that include: generic
‘‘household cleaners’’; named proprietary products such as ‘‘Omo’’; antiseptic solutions;
vinegar; lemon juice. Can be with or without specific mention of fingers, other materials, or
douching devices to introduce liquid inside the vagina.
Cloth to wipe out vagina
or apply products
Use inside the vagina, beyond the introitus, of materials such as cloth, tissue, paper, cotton
wool to wipe out vaginal secretions or to apply products. Includes specific practices described
as ‘‘cleaning with cloth’’ without any other product and named products introduced with cloth
or other material. Does not include use of medication, tampons, or removal of menstrual
blood.
Insertion of products to
dry or tighten vagina
Pushing or placing mostly nonliquid products inside the vagina (including powders, creams,
herbs, tablets, sticks, stones, leaves, ‘‘traditional products’’) regardless of the duration. Some
questions ask specifically about the use of this practice before sexual intercourse. The
intention is to achieve a sensation described as dry or tight.
Any (or no) current
practice
Includes all positive (or negative) responses to general questions about the use of an
intravaginal practice, or to specific questions about practices described above. Time period is
that asked about at the baseline visit, usually past 1–3 mo.
Categories are not mutually exclusive. Definitions of intravaginal cleaning and insertion adapted from classification developed
by the WHO Gender, Sexuality and Vaginal Practices Study Group (GSVP Study Group) [6]. Additional definitions based on
specific questions used in individual studies.
Intravaginal Practices and HIV Infection
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Description of Studies
We assessed 22 studies for eligibility; 13 prospective studies
conducted in sub-Saharan Africa included in our previous
systematic review [8,19,20,26–35] and nine identified through
expert meetings [15,36–43]. We excluded five studies for which we
could not determine eligibility because we did not establish contact
with the authors [26–28,31,33], three studies that did not include
data on relevant exposures or outcomes [30,32,34], and four
studies for which the investigators declined to take part, or could
not send their agreement to participate or dataset by 16th March
2009 (Figure 1; Table S1) [29,38–40]. We included ten studies
[8,15,19,20,35–37,41–43]. We analysed the data as 13 separate
studies, stratifying results from three multicentre studies according
to enrolment site [15,19,35]. Table 1 shows selected characteristics
of the studies, which were done in six sub-Saharan African
countries and included data from 14,874 women followed for
21,218 woman years, with 791 incident HIV infections in the first
2 y. The individual studies were generally assessed as having a low
risk of bias (data available on request). Most studies involved
women enrolled from community settings or clinics providing
reproductive health services (studies 1, 6, 7, 8, 9, 10). Two studies
in Tanzania enrolled women working as food sellers or in bars and
other recreational facilities, amongst whom high prevalences of
sexually transmitted infections and HIV have previously been
Figure 1. Flow diagram of included studies.
doi:10.1371/journal.pmed.1000416.g001
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Study
Number;
Country
[Reference]
Enrolment
Settings
Study
Population
Planned
Study
Duration
a
Planned
Frequency
of Follow-
up
a
Dates of
Enrolment
a
n
Included
b
Age at
Enrolment
(y), Mean
(SD)
Follow-
up per
Woman
(mo),
Median
(IQR)
Percent
Followed
for 12 mo
c
n
Incident
HIV
Infections
HIV
Incidence,
per 100
Woman
Years
(95% CI)
1; Uganda
[35]
FPC and
other health
services
Women
attending
clinics
15–24 mo 3 Monthly 11/99–03/02 2,201 24.9 (4.5) 23.7
(21.4–24.0)
97.0 63 1.6
(1.2–2.0)
2; Kenya
[37]
Randomised
trial (all
women);
peer-leaders
network
Self-identified
female sex
workers
24 mo 6 Monthly 05/98–01/02 414 29.1 (8.0) 23.8
(11.2–24.0)
75.4 30 4.9
(3.4–7.0)
3; Kenya
[8]
Municipal
STI clinic
Self-identified
female sex
workers
attending a
STI clinic
Not fixed Monthly 02/93–12/02 1,270 27.1 (6.3) 14.3
(3.7–24.0)
55.1 164 11.3
(9.7–13.2)
4; Tanzania
[42]
Reproductive
health clinics
in selected
guesthouses
Women
working in
bars,
restaurants,
guesthouses
12 mo 3 Monthly 08/02–10/03 978 30.0 (8.2) 11.7
(8.7–12.0)
66.0 23 2.8
(1.9–4.3)
5; Tanzania
[43]
Randomised
trial (all
women);
mobile health
clinics
Women
working
in bars,
restaurants,
guesthouses
30 mo 3 Monthly 11/03–01/06 781 27.5 (5.0) 24.0
(15.5–24.0)
91.3 45 3.4
(2.6–4.6)
6; Malawi
[19]
FPC, postnatal
clinics
Women
attending
clinics
9 mo 3 Monthly 06/01–08/02 993 27.9 (8.2) 9.0
(8.7–9.1)
67.5
c 33 4.9
(3.5–6.9)
6; Zimbabwe
[19]
As above As above As above As above As above 526 29.0 (8.4) 9.0
(8.8–9.2)
74.7
c 19 5.2
(3.3–8.1)
1; Zimbabwe
[35]
FPC and
other health
services
Women
attending
clinics
15–24 mo 3 Monthly 11/99–08/02 2,248 25.9 (4.4) 23.0
(17.3–24.0)
90.7 153 4.2
(3.6–4.9)
7; Zimbabwe,
[15]
Randomised
trial (control
arm only);
FPC,
well-baby,
general
health clinics;
community
organisations
Sexually
active
women
(average
four sex
acts per
month)
12–24 mo 3 Monthly 09/03–10/05 1,229 28.4 (7.2) 23.5
(17.9–23.9)
96.2 52 2.5
(1.9–3.3)
7; South
Africa [15]
As above As above As above As above As above 1,247 28.9 (8.0) 17.9
(14.4–22.3)
91.9 151 5.5
(4.5–6.7)
8; South
Africa [36]
FPC,
well-baby,
postnatal
clinics
Women
attending
clinics
12 mo 6 Monthly 01/02–01/04 694 24.7 (5.0) 11.0
(10.8–11.4)
74.1 20 3.4
(2.2–5.3)
9; South
Africa [41]
FPC,
immunisation
clinics
Women
attending
clinics
12 mo 3 Monthly 07/03–07/04 261 29.3 (9.5) 9.5
(6.0–12.0)
42.9 29 15.1
(10.5–21.8)
10; South
Africa [20]
Cervical
cancer trial;
community
meetings
and health
workers
Women
never
screened for
cervical cancer
living in
Khayelitsha
6–36 mo 3 Monthly 08/01–11/03 2,032 43.2 (6.8) 24.0
(24.0–24.0)
90.9 61 1.7
(1.3–2.2)
Number of incident HIV infections during up to 2 y follow-up (n=14,874), ordered geographically from north to south.
aFrom study protocol or publication.
bIncludes only women who were HIV negative at start of follow-up and had at least one follow-up visit.
cIncludes women who attended a follow-up visit at 12 mo 630 d, except study 6, which includes women who completed study follow-up at 9 mo.
FPC, family planning clinic; SD, standard deviation; STI, sexually transmitted infections.
doi:10.1371/journal.pmed.1000416.t001
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who were self-identified sex workers (studies 2, 3). The mean age at
enrolment was 29.4 y (standard deviation [SD] 8.7, range 15.2–
67.0 y). The incidence of HIV infection in individual studies
ranged from 1.6 (95% CI 1.2–2.0, study 1 Uganda) to 15.1 (95%
CI 10.5–21.8, study 9) per 100 woman years. The median time
from enrolment to the estimated date of HIV infection was 250 d
(interquartile range [IQR] 130–415 d).
Frequency of Intravaginal Practices
The percentage of women reporting any current intravaginal
practice at baseline ranged from 18% (study 8) to 95% (study 3,
Table 2). Studies done in South Africa tended to have a low
overall prevalence of any current vaginal practice (18%–27%,
studies 8–10) and studies in Zimbabwe tended to have a high
prevalence (69%–92%, studies 1, 6, 7). Female sex workers in
Kenya (76%–95%, studies 2, 3) and high risk women in Tanzania
(67%–76%, studies 5, 4) also reported high levels of any vaginal
practice. Table 2 shows the proportions of women reporting any
use of specific practices, i.e., whether or not they reported other
practices. Cleaning inside the vagina with soap was the most
common practice involving a specified product, and was reported
by more than one-third of women in six studies in the most
northern countries in the region (studies 1–6 Malawi). Reported
use of other more abrasive household cleaning products was
uncommon, ranging from 0.7% (study 8) to 7% (study 2).
Reported use of cloth or paper to wipe out the vagina, or apply
products, ranged from 0.3% (study 8) to 70% (study 7 Zimbabwe).
Inserting products to dry or tighten the vagina was uncommon;
this was most commonly reported in four studies conducted in
South Africa and Zimbabwe, where the prevalence was 13%–20%
(studies 1 Zimbabwe, 7 Zimbabwe, and 8 South Africa). Cleaning
with water, with or without other practices, was reported by more
than 60% of women in all but four studies in South Africa (studies
7 South Africa, 8–10). Where measurements of intravaginal
practices were available at follow-up visits, the majority of reported
practices were consistent with baseline data; 60% reported the
same practice at all study visits at which data were collected, 34%
reported either the same practice or no practice, and 6% reported
different practices at all visits.
Associations between Intravaginal Practices and HIV
Infection
Intravaginal use of cloth or paper to wipe out the vagina or apply
products was the practice most strongly associated with HIV
acquisition in univariable analysis and after controlling for age,
marital status, and number of sex partners in the past 3 mo (pooled
adjusted HR 1.47, 95% CI 1.18–1.83) (Figure 2). There was also an
increased risk of HIV acquisition in women reporting intravaginal
cleaning with soap and water (pooled adjusted HR 1.24, 95% CI
1.01–1.53) (Figure 3) and insertion of products to dry or tighten the
vagina (pooled adjusted HR 1.31, 95% CI 1.00–1.71) (Figure 4).
One study (study 2) did not ask about insertion practices. The use of
household cleaning products other than soap was much less
common; in four studies the HR could not be estimated (studies 1
Uganda, 4, 5, 8; Figure 5). In the remaining studies the pooled
analyses showed no evidence of an increased risk of HIV acquisition
(pooled adjusted HR 1.11, 95% CI 0.73–1.68). There was little
evidence of between-study heterogeneity in any of these analyses (I
2
values 0%–14%). Results from the fixed effects models were the
same or very similar to those fromrandomeffects models(Table S2).
There was no statistical evidence that intravaginal use of water
alone increased the risk of HIV acquisition when compared with
no practice in univariable (Table S3, pooled unadjusted HR 1.02,
Table 2. Baseline prevalence of intravaginal practices and BV in included cohort studies (n=14,874).
Study Number;
Country n Included
Any
Practice
a Specific Practices n BV (%)
n Yes (%)
n Cleaning
with Water
Only (%)
b
n Cleaning
with Water
(%)
c
n Cleaning
with Soap
(%)
c
n Cleaning with
Household
Products (%)
c
n Use of
Cloth,
Tissue,
Paper (%)
c
n Insertion to Dry/
Tighten (%)
c
1; Uganda 2,201 1,510 (68.6) 500 (22.7) 1,492 (67.8) 982 (44.6) 32 (1.5) 195 (8.9) 30 (1.4) 465 (21.1)
2; Kenya 414 323 (78.0) Not asked 273 (65.9) 207 (50.0) 30 (7.3) 2 (0.5) Not asked 197 (47.6)
3; Kenya 1,270 1,204 (94.8) 243 (19.1) 1,066 (83.9) 820 (64.6) 85 (6.7) 187 (14.7) 11 (0.9) 461 (36.3)
4; Tanzania 978 740 (75.7) 372 (38.0) 728 (74.4) 348 (35.6) 8 (0.8) 32 (3.3) 26 (2.7) 446 (45.6)
5; Tanzania 781 523 (67.0) 101 (11.1) 499 (63.9) 397 (50.8) 16 (2.1) 32 (4.1) 33 (4.2) 482 (61.7)
6; Malawi 993 891 (89.7) 182 (18.3) 880 (88.6) 669 (67.4) 23 (2.3) 47 (4.7) 33 (3.3) 77 (7.8)
6; Zimbabwe 526 364 (69.2) 262 (49.8) 356 (67.7) 68 (12.9) 18 (3.4) 29 (5.5) 6 (1.1) 85 (16.2)
1; Zimbabwe 2,248 1,916 (85.2) 1,323 (58.9) 1,724 (76.7) 320 (14.2) 106 (4.7) 1,122 (49.9) 445 (19.8) 639 (28.4)
7; Zimbabwe 1,229 1,127 (91.7) 629 (51.2) 810 (65.9) 166 (13.5) 41 (3.3) 854 (69.5) 154 (12.5) 82 (6.7)
d
7; South Africa 1,247 1,123 (90.1) 86 (6.9) 668 (53.6) 582 (46.7) 49 (3.9) 655 (52.5) 164 (13.2) 0
d
8; South Africa 694 124 (17.9) 19 (2.7) 44 (6.3) 17 (2.5) 5 (0.7) 2 (0.3) 87 (12.5) 349 (50.3)
9; South Africa 261 68 (26.1) 19 (7.3) 56 (21.5) 36 (13.8) 14 (5.4) 37 (14.2) 8 (3.1) 124 (47.5)
10; South Africa 2,032 546 (26.9) 304 (15.0) 460 (22.6) 103 (5.1) 85 (4.2) 438 (21.6) 154 (7.6) 174 (8.6)
aIncludes any intravaginal practice reported at the baseline visit.
bWater is the only substance put into the vagina and woman does not use any other intravaginal practice (this category was grouped with ‘‘no intravaginal practice’’ to
form the reference category for comparative analyses).
cWoman reports using this practice and may or may not report any other intravaginal practice.
dBased on a subset of 257 women tested for BV at baseline in the Zimbabwe study site only.
doi:10.1371/journal.pmed.1000416.t002
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PLoS Medicine | www.plosmedicine.org 6 February 2011 | Volume 8 | Issue 2 | e1000416Figure 2. Association between use of cloth or paper to wipe out vagina or apply products and HIV acquisition, ordered by country,
north to south (n=10,332). Individual study results from Cox regression. Pooled unadjusted and aHRs from random effects meta-analysis.
Reference group is women who reported no intravaginal practice or cleaning with water only. Multivariable models adjusted for age, marital status,
and number of partners in last 3 mo. No estimate possible if there were no events in one group.
doi:10.1371/journal.pmed.1000416.g002
Figure 3. Association between intravaginal cleaning with soap and HIV acquisition, ordered by country, north to south (n = 3,071).
Individual study results from Cox regression. Pooled unadjusted and aHRs from random effects meta-analysis. Reference group is women who
reported no intravaginal practice or cleaning with water only. Multivariable models adjusted for age, marital status, and number of partners in last
3 mo.
doi:10.1371/journal.pmed.1000416.g003
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PLoS Medicine | www.plosmedicine.org 7 February 2011 | Volume 8 | Issue 2 | e1000416Figure 4. Association between insertion of products to dry or tighten the vagina and HIV acquisition, ordered by country, north to
south(n=9,420). Individual study results from Cox regression. Pooled unadjusted and aHRs from random effects meta-analysis. Reference group is
women who reported no intravaginal practice or cleaning with water only. Multivariable models adjusted for age, marital status, and number of
partners in last 3 mo. No estimate possible if there were no events in one group. Stratum excluded if there were no events in either group, or
standard error could not be estimated by model.
doi:10.1371/journal.pmed.1000416.g004
Figure 5. Association between intravaginal cleaning with household cleaners and HIV acquisition, ordered by country, north to
south (n=8,879). Individual study results from Cox regression. Pooled unadjusted and aHRs from random effects meta-analysis. Reference group is
women who reported no intravaginal practice or cleaning with water only. Multivariable models adjusted for age, marital status, and number of
partners in last 3 mo. No estimate possible if there were no events in one group.
doi:10.1371/journal.pmed.1000416.g005
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2 3.9%) or multivariable analyses (pooled
adjusted HR 1.03, 95% CI 0.76–1.40, I
2 16.1%). Women who
used only water intravaginally, compared with those using no
practice, were younger (p,0.001), more likely to be currently
married (p,0.001), more likely to have one partner in the last
3m o( p,0.001), more likely to be using contraception (p,0.001),
more likely to be Catholic or Muslim than Protestant (p,0.001),
and less likely to never use condoms (p=0.005). Controlling for
these variables did not alter the strength of the associations found
in univariable analyses (unpublished results).
Table 3 shows the results of analyses controlling for BV in
addition to demographic and behavioural characteristics. These
analyses exclude most participants from study 7, in whom vaginal
flora was only assessed in a subset of women from one study site.
Intravaginal use of cloth or paper remained associated with HIV
acquisition after controlling for BV. For cleaning with soap and
insertion of products to dry or tighten the vagina, the associations
with HIV acquisition were weakened slightly after adjustment for
demographic and behavioural variables. Adjustment for the
presence of BV at baseline or at the last visit before the estimated
date of HIV infection did not have any additional effect. When
vaginal flora status was considered with intermediate vaginal flora
and BV as separate categories, the pattern of results was similar to
that seen when BV was included as a binary variable, but
confidence intervals were wider because studies that used only
Amsel criteria for diagnosis were excluded (unpublished results).
Associations between Intravaginal Practices and
Disrupted Vaginal Flora
Table 4 shows the associations between intravaginal practices
and the development of intermediate vaginal flora or BV amongst
women with normal vaginal flora at the baseline visit and vaginal
specimens examined by Gram-stain criteria at follow-up. Amongst
women who cleaned intravaginally with soap and water, the
incidence of disrupted vaginal flora at the next visit was increased in
univariable and multivariable analyses (pooled adjusted OR from
ordered logistic regression 1.24, 95% CI 1.04–1.47). There was a
similar but weaker trend for the insertion of products to dry or
tighten the vagina, but confidence intervals for these estimates were
wider (pooled adjusted OR 1.29, 95% CI 0.98–1.71, p=0.072).
There was no evidence of an association between intravaginal
cleaning with household products or use of cloth or paper and
development of disrupted vaginal flora. There was no evidence of
between-study heterogeneity (I
2 values 0.0% for all analyses).
Associations between Disrupted Vaginal Flora and HIV
Infection
Vaginal flora status was associated with HIV incidence in
univariable and multivariable analyses (Table 5). The risk of HIV
acquisition was higher in women with BV than with intermediate
vaginal flora. Controlling for potential confounders did not
substantially attenuate the effect estimates. The strength of
association between vaginal flora status and HIV acquisition was
slightly weaker when using the vaginal flora status measured at the
visit preceding the estimated date of HIV infection (median 51 d,
IQR 40–147 d between vaginal flora assessment and HIV
infection) than when using the baseline value (median 253 d,
IQR 116–426 d).
Discussion
This study combined individual participant data from ten
prospective studies in six sub-Saharan African countries. Intra-
vaginal use of cloth or paper remained associated with HIV
acquisition after controlling for age, marital status, number of sex
partners in the past 3 mo, and in models that controlled for BV.
Insertion of products to dry or tighten the vagina and intravaginal
cleaning with soap were associated with HIV acquisition in
univariable and multivariable analyses controlling for demograph-
ic and behavioural variables, but not in models that controlled for
BV. Intravaginal cleaning with soap was also associated with the
development of intermediate vaginal flora and BV at follow-up in
women with normal vaginal flora at baseline. Disrupted vaginal
flora measured at baseline or at the visit before the estimated data
of HIV infection was associated with HIV acquisition in both
univariable and multivariable analyses.
Strengths and Weaknesses
The main strength of this study was the collaboration of
investigators from ten different studies, which allowed the collation
of individual participant data from nearly 15,000 women and
analysis using consistent definitions of intravaginal practices across
studies. By pooling data we increased the power and precision of
our analyses and adjusted for confounding, which is difficult or
impossible in an aggregate data meta-analysis [14]. There was a
striking lack of between-study heterogeneity in results, despite
differences in study populations, designs, and questionnaires,
which increases the robustness of our findings. In addition, we
obtained very similar results using different statistical methods to
pool data. Our results might be biased because we did not identify
or include all eligible studies. We did, however, conduct a wide-
ranging search and reasons for exclusion were not related to study
results.
Limitations of this study were mainly due to data collection
differences that could not be remedied by recoding. Questions
about intravaginal practices were asked in different ways because
there are no agreed upon definitions [5], there is no validated
measurement instrument, and the purposes of the studies differed.
We therefore had to limit the number of specific intravaginal
practices from those originally planned and differences in wording
of questions about intravaginal practices between studies might
have affected our results. By grouping exposure categories, we
might have masked harms (or benefits) of particular practices or
products. Grouping of categories to obtain uniformly defined
variables for confounding factors, or imprecision in the measure-
ment of other variables included in the analysis might also have
resulted in residual confounding. In addition, we cannot exclude
the possibility of residual confounding from unmeasured factors,
such as sexually transmitted infections, from our reliance on
baseline measures of intravaginal practices that changed over time,
or the motivation for performing certain practices, which can vary
according to perceptions of risk [5].
A further limitation was the difficulty in definitively establishing
the temporal sequence of intravaginal practices and changes in
vaginal flora status; intravaginal practices could promote disrup-
tion of vaginal flora but symptoms related to those changes, such
as vaginal discharge or fishy odour, could prompt intravaginal
washing or wiping [24]. We tried to overcome this problem when
examining the association between intravaginal practices and
disrupted vaginal flora by including only women with normal
vaginal flora at baseline. We could not, however, consider changes
in exposure status over time because of data collection differences
and uncertainty about the effects of treatment for BV, which was
documented in some studies but not in others.
Comparison with Other Studies
This study is likely to be the largest to have examined
associations between intravaginal practices and HIV acquisition
Intravaginal Practices and HIV Infection
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inconsistencies between published studies. For example, McClel-
land and colleagues found a strong association between intravag-
inal cleaning with soap and incident HIV infection in Kenya [8]
but van de Wijgert and colleagues and Myer and colleagues found
no associations in their studies in Uganda and Zimbabwe [44] and
South Africa [20]. In this analysis, estimates from the same studies
were close to the published data; when pooled with the other
studies, using the same definitions and multivariable model, the
results were consistent with the overall finding of a modest increase
in the risk of HIV acquisition (Figures 1–4). Differences in
definitions of intravaginal practices and methods of analysis in
individual studies make it difficult to compare findings directly and
to synthesise results across studies. These differences meant that in
Table 3. Associations between intravaginal practices and HIV acquisition, adjusting for different measures of disrupted vaginal
flora.
Intravaginal
Practice
Number
in Model
(Strata/
Studies)a
HR
(95% CI)
aHR
(95% CI)
Unadjusted
I
2%
(95%
CI)
Demographic/
Behavioural Factors
b
I
2%
(95%
CI)
Demographic/Behavioural
Factors + BV
c at Baseline
I
2%
(95%
CI)
Demographic/Behavioural
Factors + BV
{ before
Seroconversion
I
2%
(95%
CI)
Cleaning
with soap
and water
11,387
(12/10)
1.20
(0.97–1.49)
8.2
(0–62)
1.18 (0.94–1.48) 14.3
(0–54)
1.18 (0.94–1.49) 15.8
(0–55)
1.18 (0.94–1.48) 13.6
(0–53)
Cleaning
with
household
products
7,893
(12/10)
1.20
(0.78–1.85)
0.0
(0–58)
1.19 (0.77–1.84) 0.0
(0–60)
1.25 (0.80–1.94) 0.0
(0–60)
1.18 (0.76–1.83) 0.0
(0–62)
Cloth to
wipe out
vagina or
apply
products
8,475
(12/10)
1.44
(1.13–1.82)
0.0
(0–58)
1.38 (1.06–1.80) 6.5
(0–61)
1.39 (1.06–1.81) 6.9
(0–61)
1.38 (1.03–1.85) 15.9
(0–56)
Insertion
of products
to dry or
tighten
vagina
8,216
(11/9)
1.36
(1.01–1.85)
0.0
(0–60)
1.32 (0.97–1.79) 0.0
(0–60)
1.33 (0.98–1.82) 0.0
(0–60)
1.32 (0.97–1.80) 0.0
(0–62)
HRs from two-stage random effects meta-analysis. Intravaginal practices measured at baseline; reference category is no vaginal practice or use of water only.
aNumbers of observations differ from Figures 1–4 because they exclude those with no BV measurement, mostly from study 7 in which BV was measured only in a subset
at baseline in the Zimbabwe site; model for insertion of products also excludes study 2, which did not ask about this practice.
bAdjusted for age, marital status, and reported number of sex partners in last 3 mo, as recorded at cohort entry.
cBV as binary variable defined as Nugent score of 7–10, Ison-Hay grade III, or the presence of three or more Amsel criteria.
doi:10.1371/journal.pmed.1000416.t003
Table 4. Associations between intravaginal practices and disrupted vaginal flora in women with normal vaginal flora at baseline.
Intravaginal
Practicea
Number in Model
(Strata/Studies)b
Number Developing
Disrupted Florac Disrupted Vaginal Flora
b
Unadjusted OR
(95% CI) p-Value
Adjusted OR
(95% CI)
d p-Value
Cleaning with soap
and water
3,222 (8/7) 1,088 1.27 (1.07–1.50) 0.006 1.24 (1.04–1.47) 0.014
Cleaning with
household products
2,045 (7/6) 641 0.95 (0.62–1.44) 0.797 0.89 (0.58–1.36) 0.576
Cloth to wipe out
vagina or apply products
2,177 (5/4) 704 1.06 (0.85–1.32) 0.588 1.06 (0.85–1.33) 0.577
Insertion of products
to dry or tighten vagina
2,264 (7/6) 735 1.26 (0.96–1.66) 0.099 1.29 (0.98–1.71) 0.072
OR from two-stage random effects meta-analysis based on ordered logistic regression.
aBaseline category for intravaginal practices is no vaginal practice or use of water only. Intravaginal practices measured at baseline.
bDisrupted vaginal flora as a three-level ordered categorical variable: normal vaginal flora defined as Nugent score 0–3, or Ison-Hay grade I; intermediate vaginal flora
defined as Nugent score 4–6, or Ison-Hay grade II; BV defined as Nugent score 7–10, or Ison-Hay grade III. Excludes two studies that did not use Gram stain criteria
[19,20].
cNumber with normal flora at baseline who developed disrupted vaginal flora includes both women using and not using each intravaginal practice.
dAdjusted for age, marital status, and reported number of sex partners in last 3 mo as reported at cohort entry.
doi:10.1371/journal.pmed.1000416.t004
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limited to examining associations with intravaginal cleaning and
insertion of products and could not draw conclusions about any
specific practice [12], illustrating the advantages of individual
participant data meta-analysis.
Our findings about the associations between disrupted vaginal
flora and increased risk of HIV are consistent with those of other
studies [10,11]. Given the rapid fluctuations that occur in vaginal
microflora [11,45], the intervals between assessment of vaginal
flora status and HIV acquisition in our analyses, and those of
previous studies, likely resulted in substantial misclassification.
However, these analyses captured some of the increase in risk of
HIV infection for women who had BV identified on at least one
occasion. A disadvantage of our analysis is that this was a
secondary objective and our search strategy did not include all
studies addressing these associations. Nevertheless, we included
more prospective studies than the previously published systematic
review examining the links between BV and risk of HIV infection
[10] and we were able to conduct both univariable and
multivariable analyses across all studies.
Interpretation of Study Findings
Our findings suggest an increase in the risk of acquiring HIV
infection amongst women who use cloth or paper to wipe out the
vagina or apply products, insert products intended to dry or
tighten the vagina, or clean with soap intravaginally. Whilst effects
of this magnitude could result from residual confounding or bias,
there are also plausible biological mechanisms for these associa-
tions. Use of cloth or paper to wipe out the vagina was associated
with HIV acquisition after controlling for BV and was not
associated with the development of disrupted flora. Use of cloth
might increase the risk of HIV if removal of protective vaginal
mucus exposes existing micro-trauma or causes inflammation or
micro-trauma [4], especially if used frequently, as reported in
some regions [5]. Insertion of products into the vagina could also
directly cause micro-trauma and/or inflammation. Since the
products used are often intended to dry or to tighten the vagina in
preparation for sexual intercourse [5], viral entry through breaks
in the cervico-vaginal epithelium could be facilitated during or
after sex [4]. We found only indirect support in this study for the
hypothesis linking intravaginal cleaning with soap, disruption of
vaginal flora, and HIV acquisition [12,20]. Amongst women with
normal vaginal flora at baseline, those who reported cleaning with
soap were slightly more likely to develop intermediate vaginal flora
and BV, possibly because an alkaline pH might promote the
growth of BV-associated bacteria. The presence of both
intermediate vaginal flora and BV were also associated with an
increased incidence of HIV in this study, confirming recent
observations [11]. We could not examine the effect of BV in a
causal model, as planned. In exploratory analyses, adjustment for
BV in addition to demographic and behavioural variables in a
standard regression model did not further alter the association
between intravaginal cleaning with soap and HIV. The adjusted
effect size will not have been estimated precisely in this model,
Table 5. Association between disrupted vaginal flora and HIV acquisition, stratified Cox regression.
Variable Baseline Vaginal Flora Status (n=8,452)
a
Vaginal Flora Status at Visit before HIV Seroconversion
(n=8,626)
a
Unadjusted HR
(95% CI)
Adjusted HR
(95% CI)
b p-Value
Unadjusted HR
(95% CI)*
Adjusted HR
(95% CI)
b p-Value
Vaginal flora ,0.001 ,0.001
Normal vaginal flora 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Intermediate vaginal
flora
1.62 (1.27–2.08) 1.54 (1.20–1.97) 1.51 (1.19–1.91) 1.41 (1.12–1.79)
BV 1.84 (1.48–2.28) 1.69 (1.36–2.10) 1.66 (1.35–2.05) 1.53 (1.24–1.89)
HSV status at baseline
Negative 1 (reference) 1 (reference)
Positive 2.14 (1.70–2.70) 2.29 (1.80–2.90) ,0.001 2.14 (1.70–2.69) 2.31 (1.82–2.91) ,0.001
Age at cohort entry ,0.001 ,0.001
.25 y 1.25 (1.04–1.50) 1.37 (1.13–1.65) 1.26 (1.05–1.52) 1.38 (1.14–1.66)
25–34 y 1 (reference) 1 (reference) 1 (reference) 1 (reference)
35 y or older 0.80 (0.56–1.15) 0.80 (0.56–1.15) 0.79 (0.55–1.13) 0.78 (0.54–1.12)
Marital status ,0.001 ,0.001
Currently married 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Currently unmarried 1.96 (1.46–2.64) 1.78 (1.32–2.40) 1.96 (1.46–2.62) 1.77 (1.31–2.38)
Number of partners
last 3 mo
0.034 0.023
No partner 0.97 (0.48–1.97) 0.94 (0.46–1.91) 0.96 (0.47–1.95) 0.90 (0.44–1.84)
1 partner 1 (reference) 1 (reference) 1 (reference) 1 (reference)
More than 1 partner 2.14 (1.47–3.12) 1.59 (1.09–2.31) 2.15 (1.48–3.13) 1.62 (1.11–2.35)
aIncluded in analysis are women with available vaginal flora status measured by Gram stain criteria: normal vaginal flora defined as Nugent score 0–3, or Ison-Hay grade
I; intermediate vaginal flora defined as Nugent score 4–6, or Ison-Hay grade II; BV defined as Nugent score 7–10, or Ison-Hay grade III. Excludes two studies that did not
use Gram stain criteria [19,20].
bMultivariable model controls for all variables in the table.
doi:10.1371/journal.pmed.1000416.t005
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Contrary to expectation [4], use of household cleaners, vinegar, or
lime juice did not increase HIV risk in this study. Lime juice has
been reported to cause vaginal epithelial damage in clinical studies
[46]. These practices were, however, reported infrequently so our
study might have lacked statistical power to answer this question,
or measurement error might have reduced our ability to detect
modest effects despite pooling data from multiple studies.
Implications for Research and Policy
It is becoming increasingly important to understand the
distribution, motivations for, and health effects of intravaginal
practices [12,47], particularly since a randomised controlled trial
has, for the first time, shown that a vaginal microbicide can reduce
acquisition of HIV infection [48]. Abdool Karim and colleagues
found that the incidence of HIV in women using the antiretroviral
agent tenofovir was 39% (95% CI 6%–60%) lower than in women
using placebo gel [48]. Whilst reported to be acceptable, there are
reasons why intravaginal practices might reduce the effectiveness of
microbicides. Women might wash or wipe out microbicides, even
when advised not to use habitual intravaginal practices during trials.
In Tanzania, about half of women who washed intravaginally
reported doing so within 2 h of intercourse [47]. Women who use
intravaginal practices might adhere less to vaginal gels, as observed in
a trial of the effectiveness of diaphragms and lubricant gel [49].
Alternatively, products inserted into the vagina might react with
microbicides, making them inactive or potentially harmful [6]. New
female-initiated interventions also need to be developed despite the
challenges involved in measuring the impact on preventing HIV
acquisition. Behavioural interventions that have been successful in
helping young US women to stop vaginal douching [50] might be
adapted for women in sub-Saharan Africa to encourage less harmful
practices [7] such as use of water alone, which was not associated with
an increased risk of HIV acquisition. This study provides evidence to
suggest that some intravaginal practices increase the risk of HIV
acquisition but a direct causal pathway linking intravaginal cleaning
with soap, disruption of vaginal flora, and HIV acquisition has not yet
been demonstrated. More consistency is needed in definitions and
measurements of intravaginal practices so that the effects of specific
intravaginal practices and products can be further elucidated.
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Background. Since the first reported case of acquired
immunodeficiency syndrome (AIDS) in 1981, the number of
people infected with the human immunodeficiency virus
(HIV), which causes AIDS, has risen steadily. By the end of
2009, an estimated 33.3 million people were living with HIV/
AIDS. At the beginning of the epidemic, more men than
women were infected with HIV but now, globally, more than
half of all adults living with HIV/AIDS are women, and HIV/
AIDS is the leading cause of death among women of child-
bearing age. In sub-Saharan Africa, where more than two-
thirds of HIV-positive people live, the situation for women is
particularly bad. About 12 million women live with HIV/AIDS
in this region compared with about 8 million men; among
15–24 year-olds, women are eight times more likely than
men to be HIV-positive. This pattern of infection has
developed because in sub-Saharan Africa most people
contract HIV through heterosexual sex.
Why Was This Study Done? If modifiable factors that
increase women’s vulnerability to HIV infection could be
identified, it might be possible to develop effective female-
initiated prevention interventions. Some experts think that
intravaginal practices such as cleaning the vagina with soap
or a cloth increase the risk of HIV infection by damaging the
vagina’s lining or by increasing bacterial vaginosis (a
condition in which harmful bacteria disrupt the healthy
vaginal flora) but the evidence for such an association is
inconclusive. In this meta-analysis, the researchers pool
individual participant data from several prospective
longitudinal cohort studies to assess the association
between intravaginal practices and HIV acquisition among
women in sub-Saharan Africa. Meta-analysis is a statistical
method that combines data from several studies to get a
clearer view of the factors associated with of a disease than is
possible from individual studies. In a prospective
longitudinal cohort study, groups of participants with
different baseline characteristics (here, women who did or
did not use intravaginal practices), who do not have the
outcome of interest at the start of the study (here, HIV
infection) are followed to see whether these characteristics
affect disease development.
What Did the Researchers Do and Find? The researchers
pooled individual participant data from 13 prospective
cohort studies in sub-Saharan Africa involving nearly
15,000 women, 791 of whom acquired HIV, and asked
whether HIV infection within 2 years of study enrollment was
associated with self-reported intravaginal practices. That is,
were women who used specific intravaginal practices more
likely to become infected with HIV than women who did not
use these practices? After controlling for age, marital status,
and the number of recent sex partners, women who used
cloth or paper to clean their vagina were nearly one and half
times more likely to have acquired HIV infection as women
who did not use this practice (a pooled adjusted hazard ratio
[aHR] of 1.47). The insertion of products to dry or tighten the
vagina and intravaginal cleaning with soap also increased
women’s chances of acquiring HIV (aHRs of 1.31 and 1.24,
respectively). Moreover, intravaginal cleaning with soap was
associated with the development of bacterial vaginosis, and
disrupted vaginal flora and bacterial vaginosis were both
associated with an increased risk of HIV acquisition.
What Do These Findings Mean? These findings suggest
that some intravaginal practices increase the risk of HIV
acquisition but they do not prove that there is a causal link
between any intravaginal practice, disruption of vaginal flora,
and HIV acquisition. It could be that the women who use
intravaginal practices share other unknown characteristics
that affect their vulnerability to HIV infection. The accuracy of
these findings is also likely to be affected by the use of self-
reported data and inconsistent definitions of intravaginal
practices. Nevertheless, given the widespread use of
intravaginal practices in some sub-Saharan countries (95%
of female sex workers in Kenya use such practices, for
example), these findings suggest that encouraging women
to use less harmful intravaginal practices (for example,
washing with water alone) should be included in female-
initiated HIV prevention research strategies in sub-Saharan
Africa and other regions where intravaginal practices are
common.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000416
N The US National Institute of Allergy and Infectious Diseases
provides information on HIV infection and AIDS and on
bacterial vaginosis
N The US Centers for Disease Control and Prevention has
information on all aspects of HIV/AIDS, including specific
information about HIV/AIDS and women; it also has
information on bacterial vaginosis (in English and Spanish)
N HIV InSite has information on all aspects of HIV/AIDS
N Information is available from Avert, an international AIDS
nonprofit on all aspects of HIV/AIDS, including HIV/AIDS
and women and HIV/AIDS in Africa (in English and Spanish)
N A full description of the researchers’ study protocol is
available
N Several Web sites provide information on microbicides
Global Campaign for Microbicides, Microbicides Develop-
ment Programme, Microbicides Trials Network, and
International Partnership for Microbicides
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